2m 2m 2m 2m 2m 2m 2m
Belite Bio Sp ADR (BLTE)
NASDAQ
$145.35-$1.72 (-1.17%)
Price as of Jun 23, 2026 4:10 PM EDT- $5.9BMarket Cap
- 139.14%1-Year Change
- BiotechnologyIndustry
Belite Bio Sp ADR (BLTE)
$145.35-$1.72 (-1.17%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
DARWIN GLOBAL MANAGEMENT, LTD. | 7.63% | 3.1M | +29,708 (+0.97%) | Mar 31, 2026 |
PARADIGM BIOCAPITAL ADVISORS LP | 2.78% | 1.1M | +1.1M (+100.00%) | Mar 31, 2026 |
UBS GROUP AG | 1.92% | 768,359 | +639,607 (+83.24%) | Mar 31, 2026 |
RTW INVESTMENTS, LP | 1.78% | 715,332 | 0 (0.00%) | Mar 31, 2026 |
MILLENNIUM MANAGEMENT LLC | 1.42% | 570,088 | +11,206 (+1.97%) | Mar 31, 2026 |
HOLOCENE ADVISORS, LP | 1.23% | 494,495 | +410,428 (+83.00%) | Mar 31, 2026 |
EVENTIDE ASSET MANAGEMENT, LLC | 0.89% | 357,650 | -25,441 (-7.11%) | Mar 31, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
T. Rowe Price Health Sciences Fund, Inc. | 0.52% | 207,862 | +207,862 (+100.00%) | Mar 31, 2026 |
ALGER FUNDS | 0.14% | 56,833 | +56,833 (+100.00%) | Jan 30, 2026 |
MUTUAL FUND SERIES TRUST | 0.07% | 29,026 | -25,441 (-87.65%) | Mar 31, 2026 |
Brighthouse Funds Trust I | 0.04% | 15,913 | +15,913 (+100.00%) | Mar 31, 2026 |
ALPS ETF Trust | 0.04% | 15,897 | 0 (0.00%) | Feb 28, 2026 |
SPDR INDEX SHARES FUNDS | 0.04% | 15,648 | +308 (+1.97%) | Mar 31, 2026 |
T. Rowe Price Equity Series, Inc. | 0.03% | 12,700 | +12,700 (+100.00%) | Mar 31, 2026 |
Current Ownership Distribution
- Institutions22.4M (55.95%)
- Other16.4M (40.90%)
- Mutual Funds831,304 (2.07%)
- Insiders430,655 (1.07%)
Insider Transactions
- 1.07% (430,655)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 1Number of InsiderSelling (last 12 months)
- $12.0MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Scholl Hendrik Peter Chief Medical Officer | Sell | Jun 18, 2026 | $13,814.40 | 96 | $143.90 | 24,904 |
Scholl Hendrik Peter Chief Medical Officer | Sell | Jun 18, 2026 | $542,192.05 | 3,748 | $144.66 | 21,156 |
Scholl Hendrik Peter Chief Medical Officer | Sell | Jun 18, 2026 | $706,958.56 | 4,861 | $145.43 | 16,295 |
Scholl Hendrik Peter Chief Medical Officer | Sell | Jun 18, 2026 | $175,347.64 | 1,199 | $146.24 | 15,096 |
Scholl Hendrik Peter Chief Medical Officer | Sell | Jun 18, 2026 | $14,122.56 | 96 | $147.11 | 15,000 |
Chen Wan-Shan | Award | Mar 31, 2026 | $0.00 | 13,796 | $0.00 | 13,796 |
Lin Yu-Hsin Chief Executive Officer | Award | Mar 31, 2026 | $0.00 | 206,954 | $0.00 | 413,908 |
Chuang Hao-Yuan Chief Financial Officer | Award | Mar 31, 2026 | $0.00 | 144,868 | $0.00 | 289,736 |
MATA NATHAN L. Chief Scientific Officer | Award | Mar 31, 2026 | $0.00 | 144,868 | $0.00 | 267,934 |